Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant
Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…
Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23
New Delhi: Aurobindo Pharma Ltd on Tuesday said it has set April 23 as the opening date for its Rs 800 crore buyback offer. The closing date for the buyback…
Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid
New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…
Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid
Aurobindo Pharma announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per ml. The…
Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
The U.S.Food and Drug Administration has issued five observations to Aurobindo Pharma subsidiary APL Healthcare’s unit in Andhra Pradesh. The U.S.FDA inspected Unit-IV of APL Healthcare in SPSR Nellore District,…
Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet
Aurobindo Pharma, a leading player in the active pharmaceutical ingredient and generic market, has issued a statement clarifying that reports of buying out Prague-based generic drugmaker Zentiva are ‘premature’, and…
Aurobindo to Start US Units This Year; China Plant Nears Q3 FY26 Break-Even
New Delhi, August 18, 2025 — Aurobindo Pharma said two manufacturing units in the United States are slated to start production within the current fiscal, tightening the company’s supply chain…
Aurobindo Pharma to manufacture, supply long acting HIV treatment drug
Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic…
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg
Hyderabad: Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…
I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330
ICICI Securities has downgraded Aurobindo Pharma to Add (from Buy earlier) with a revised target price of Rs 1,330 (earlier Rs 1,445). The current market price of Aurobindo Pharma Ltd.…
